← Back to Search

Behavioral Intervention

Breathwork for Cannabis Use Disorder

Led By Silvia J Franco Corso, M.D
Research Sponsored by Elias Dakwar
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-70 years of age
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 24 hours after the breathing session.
Awards & highlights


This trial will test whether a breathwork intervention is safe and acceptable for people with substance use disorders.

Who is the study for?
This trial is for adults aged 18-70 who are seeking treatment for cannabis use disorder as defined by the DSM-V. It's not open to individuals with active substance use disorders (other than cannabis, nicotine, or caffeine), psychotic illnesses, dissociative disorders, severe withdrawal history, dementia, epilepsy or seizures, cardiac issues like arrhythmia or heart failure, asthma, panic disorder or other respiratory illnesses.Check my eligibility
What is being tested?
The study is testing a breathwork workshop intervention to see if it's safe and helpful for people struggling with cannabis use disorder. The goal is to assess whether this approach could be a feasible and acceptable treatment option.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention in the form of breathwork exercises there may be minimal side effects; however specific side effects are not detailed in the provided information.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I am between 18 and 70 years old.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured during breathing session
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured during breathing session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of the breathwork session
Safety of the breathing session
Secondary outcome measures
Change in Cue Reactivity
Change in Motivation to Quit
Change in cannabis use
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Breathwork groupExperimental Treatment1 Intervention
Treatment-seeking individuals with cannabis use disorder who will participate in the 1-week breathwork workshop.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Cannabis Abuse include behavioral and pharmacological approaches. Behavioral treatments like Brief Behavioral Treatment for Insomnia (BBTI) and cognitive-behavioral stress management focus on improving sleep and managing stress, which can reduce cannabis cravings and usage. Mindfulness interventions aim to decouple the association between cravings and cannabis use by promoting awareness and stress reduction. Pharmacological treatments such as varenicline, gabapentin, and cannabidiol work by modulating neurotransmitter systems to reduce cravings and withdrawal symptoms. These mechanisms are crucial for patients as they address the underlying stress and cravings that drive cannabis use, similar to the goals of controlled breathing exercises in the Breathwork Workshop.
A pilot randomized clinical trial of Brief Behavioral Treatment for Insomnia to reduce problematic cannabis use among trauma-exposed young adults.Cognitive-behavioral stress management for individuals with substance use disorders: a pilot study.

Find a Location

Who is running the clinical trial?

Elias DakwarLead Sponsor
Kate O'Malley, M.AStudy DirectorNew York State Psychiatric Institute/ Columbia University
Silvia J Franco Corso, M.DPrincipal InvestigatorNew York State Psychiatric Institute/ Columbia University Medical Center
~0 spots leftby Aug 2024